✉news HealthHealth first seen 8 h ago, last 2 h ago, peak #11
AAOpt 2026 puts GLP-1 drugs and eye health in focus
Original: AAOpt 2026: GLP-1RAs and ocular health
The American Academy of Optometry's 2026 meeting is spotlighting the ocular effects of GLP-1 receptor agonists, the class of drugs that includes semaglutide and tirzepatide. Clinicians are discussing how these widely used diabetes and weight-loss medications may affect the eye, from reported changes in diabetic retinopathy to dry-eye symptoms, and what optometrists should monitor in patients taking them.
Why now: Millions of patients now take GLP-1 drugs, so eye-care specialists are urgently weighing emerging evidence about their effects on vision and retinal health.
American Academy of OptometryGLP-1 receptor agonistssemaglutidetirzepatide
Rank over time, top of the chart is #1. 5 snapshots from 8 h ago to 2 h ago.
Evidence
- AAOpt 2026: GLP-1RAs and ocular health · Optometry Times
API: https://socialmediatrends-api.osmike.com/v1/trends/902046